Description
Chemical name: 2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
Formula: C17H19N5
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
ANASTROZOLE 1mg – HILMA BIOCARE
Anastrozole is a medication belonging to the aromatase inhibitor family, used to treat breast cancer in postmenopausal women. It contains the active substance anastrozole, which blocks the production of estrogen, a hormone that promotes the growth of certain tumors in women.
The key characteristics of Anastrozole include its relatively short half-life of two days. This means that the medication is eliminated from the body relatively quickly. It is, therefore, important to take the medication as prescribed to maintain consistent levels of the drug in the bloodstream.
The recommended daily dosage of Anastrozole ranges from 0.5 to 1 mg, and it is usually taken orally for a period of five years or more, depending on the type and stage of breast cancer. Anastrozole is available in the form of 50 pills, each containing 1 mg of the active substance.
Anastrozole is usually well-tolerated by patients and does not cause acne, water retention, high blood pressure, hepatotoxicity, or HBR. However, some common side effects may include hot flashes, joint pain, fatigue, and mood changes.
As a non-steroidal aromatase inhibitor, Anastrozole works to reduce the levels of estrogen in the body, thus slowing down the growth and spreading of certain tumors. It is usually prescribed to women who have hormone receptor-positive breast cancer, meaning that their cancer cells are fueled by estrogen.
Anastrozole is manufactured by Hilma Biocare, a company that produces high-quality medications for various medical conditions. Overall, Anastrozole is a safe and effective medication for the treatment of postmenopausal breast cancer patients, and it should only be used under the supervision of a qualified healthcare provider.
Reviews
There are no reviews yet.